Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albert J Allen

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
Drug and Alcohol Dependence|March 11, 2008
Abuse liability assessment of atomoxetine in a drug-abusing populationDonald R Jasinski, Douglas E Faries, Rodney J Moore, et al.
The Journal of Clinical Psychiatry|January 18, 2014
Atomoxetine tolerability in pediatric and adult patients receiving different dosing strategiesLinda A Wietecha, Dustin D Ruff, Albert J Allen, et al.
Sleep Medicine|August 12, 2008
Subjective and objective measures of sleep in children with attention-deficit/hyperactivity disorderJudith Owens, R Bart Sangal, Virginia K Sutton, et al.
Asia-Pacific Psychiatry : Official Journal of the Pacific Rim College of Psychiatrists|December 31, 2013
Long-term safety and tolerability of atomoxetine in Japanese adults with attention deficit hyperactivity disorderYuko Hirata, Taro Goto, Yasushi Takita, et al.
Journal of Child and Adolescent Psychopharmacology|April 24, 2013
Clinical outcomes from an open-label study of edivoxetine use in pediatric patients with attention-deficit/hyperactivity disorderLing Jin, Wen Xu, David Krefetz, et al.
Child and Adolescent Psychiatry and Mental Health|September 28, 2007
A pilot study for augmenting atomoxetine with methylphenidate: safety of concomitant therapy in children with attention-deficit/hyperactivity disorderGabrielle A Carlson, David Dunn, Douglas Kelsey, et al.
Journal of Child and Adolescent Psychopharmacology|August 2, 2012
Pharmacokinetics and pharmacodynamics of edivoxetine (LY2216684), a norepinephrine reuptake inhibitor, in pediatric patients with attention-deficit/hyperactivity disorderWilliam Kielbasa, Tonya Quinlan, Ling Jin, et al.
Pediatrics|November 15, 2006
Low-dose atomoxetine for maintenance treatment of attention-deficit/hyperactivity disorderJeffrey H Newcorn, David Michelson, Christopher J Kratochvil, et al.
Journal of Child and Adolescent Psychopharmacology|May 21, 2014
A randomized trial of edivoxetine in pediatric patients with attention-deficit/hyperactivity disorderDaniel Y Lin, Christopher J Kratochvil, Wen Xu, et al.
The Journal of Clinical Psychiatry|April 21, 2004
Prevalence of obsessive-compulsive disorder in patients with systemic lupus erythematosusMarcia J Slattery, Billinda K Dubbert, Albert J Allen, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Drug and Alcohol Dependence|March 11, 2008
Abuse liability assessment of atomoxetine in a drug-abusing populationDonald R Jasinski, Douglas E Faries, Rodney J Moore, et al.
The Journal of Clinical Psychiatry|January 18, 2014
Atomoxetine tolerability in pediatric and adult patients receiving different dosing strategiesLinda A Wietecha, Dustin D Ruff, Albert J Allen, et al.
Sleep Medicine|August 12, 2008
Subjective and objective measures of sleep in children with attention-deficit/hyperactivity disorderJudith Owens, R Bart Sangal, Virginia K Sutton, et al.
Asia-Pacific Psychiatry : Official Journal of the Pacific Rim College of Psychiatrists|December 31, 2013
Long-term safety and tolerability of atomoxetine in Japanese adults with attention deficit hyperactivity disorderYuko Hirata, Taro Goto, Yasushi Takita, et al.
Journal of Child and Adolescent Psychopharmacology|April 24, 2013
Clinical outcomes from an open-label study of edivoxetine use in pediatric patients with attention-deficit/hyperactivity disorderLing Jin, Wen Xu, David Krefetz, et al.
Child and Adolescent Psychiatry and Mental Health|September 28, 2007
A pilot study for augmenting atomoxetine with methylphenidate: safety of concomitant therapy in children with attention-deficit/hyperactivity disorderGabrielle A Carlson, David Dunn, Douglas Kelsey, et al.
Journal of Child and Adolescent Psychopharmacology|August 2, 2012
Pharmacokinetics and pharmacodynamics of edivoxetine (LY2216684), a norepinephrine reuptake inhibitor, in pediatric patients with attention-deficit/hyperactivity disorderWilliam Kielbasa, Tonya Quinlan, Ling Jin, et al.
Pediatrics|November 15, 2006
Low-dose atomoxetine for maintenance treatment of attention-deficit/hyperactivity disorderJeffrey H Newcorn, David Michelson, Christopher J Kratochvil, et al.
Journal of Child and Adolescent Psychopharmacology|May 21, 2014
A randomized trial of edivoxetine in pediatric patients with attention-deficit/hyperactivity disorderDaniel Y Lin, Christopher J Kratochvil, Wen Xu, et al.
The Journal of Clinical Psychiatry|April 21, 2004
Prevalence of obsessive-compulsive disorder in patients with systemic lupus erythematosusMarcia J Slattery, Billinda K Dubbert, Albert J Allen, et al.
Pageof 6